US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2056 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
KD2084, Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
BR10010a, Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases/100 cores, replacing BR10010
BR2082, Breast disease spectrum (breast cancer progression) tissue array, 206 cases/208 cores
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores

Newly added tissue microarrays in recent month:

2014-11-20 HLin-Ade147Lym-01, Colon adenocarcinoma (24 cases) and rectum adenocarcinoma (25 cases).
2014-11-19 HIBD-Ade100PG-01, Intrahepatic biliary cancer, 100 cases, 1 core/case.
2014-11-17 FMC407c, Frozen multiple organ cancer tissue array, 40 cases/40 cores, replacing FMC407b
2014-11-17 ST1003a, Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing ST1003
2014-11-17 BR901, Breast cancer tissue array (pathology grade 1-3), including TNM and clinical stage data, 45 cases/90 cores
2014-11-17 SO2082a, Rhabdomyosarcoma tissue array with normal striated muscle control, including TNM, clinical stage and pathology grade, 104 cases/ 208 cores
2014-11-10 CO601, Colon cancer (stage I) tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 30 cases/60 cores
2014-11-10 BR351, Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores
2014-11-10 BC081120a, Breast cancer and adjacent breast tissue array, including TNM, clinical stage and pathology grade, 110 cases/110 cores, replacing BC081120
2014-11-10 BR10010c, Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, IHC of Her-2/ER/PR to be added, 50 cases/100 cores, replacing BR10010b
2014-11-06 T032b, Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T032a
2014-11-05 HBre-Duc150Sur-01, Breast carcinoma, 150 cases, 1 core/case. Clinical stage I, II, III. Survival data followed up for 9-12 years.
2014-11-03 OV208a, Ovarian cancer and normal tissue high density tissue array, including TNM, clinical stage and pathology grade, 69 cases/ 207 cores, replacing OV208
2014-11-03 CO901, Colon cancer tissue array, with cancer adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases/90 cores
2014-11-03 LC10014a, Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, with IHC of TTF-1 results, 50 cases/100 cores, replacing LC10014
2014-11-03 LC10015a, Lung squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, with IHC of EGFR results, 50 cases/100 cores, replacing LC10015
2014-10-27 ES810a, Esophagus cancer with matched lymph node metastasis tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing ES810
2014-10-27 ME1005, Malignant melanoma tissue array, including TNM and clinical stage, with IHC of HMB-45 results, 50cases/ 100 cores
2014-10-15 FDA996, Multiple organ normal tissue array, 51 cases/99 cores, replacing FDA995
2014-10-15 MC5003b, High-density multiple organ tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 500 cases/500 cores, replacing MC5003a